• Be-Super-150687910_5760x3840.jpg

A singular threat

The World Health Organization estimates that up to 650,000 people worldwide die every year from influenza, and mathematical modeling reveals that 33 million people could die in the first 6 months of a pandemic of a highly contagious virus like influenza.

Flu Lab, a philanthropic organization launched in 2018, has a singular mission -- to fuel bold approaches to defeat influenza. Accelerated progress is only possible by addressing old problems in new, dynamic ways and we look to power transformative approaches to advance influenza research, promote open science principles, and explore new influenza solutions.

Flu Lab's Philosophy

Our perspective is driven by a sense of urgency to generate fresh thinking to achieve a world free from the dangers of influenza. Flu Lab invests in programs and partnerships that will create actionable knowledge, stimulate cross-sector collaborations, and mobilize stakeholders, driving toward this challenging, but achievable goal.


Addressing the threat

We believe that influenza is an intractable and daunting problem worthy of the time, investment and imagination necessary to eliminate the threat it poses to the world.


Transformative solutions

We believe that by de-risking new ideas and tools and by embracing experimentation and innovation, transformative solutions to influenza can be discovered, shared and activated.

Vaccine_Policy. (1) (1).jpg

Partnering for impact

We believe that by working with strategic partners and by supporting cutting-edge research and programs, we have the opportunity to make influenza history by eliminating it as a global threat.

Flu Lab's Team

Learn More About Casey

Casey Wright, CEO

Casey Wright, ScM, is the chief executive of Flu Lab. Prior to creating Flu Lab, Casey established a philanthropic program to increase school-aged influenza vaccine coverage rates and launched new research and innovation initiatives for universal influenza vaccine development. Casey’s public health experience includes over a decade of public service at the Centers for Disease Control and Prevention and the U.S. Department of Health and Human Services (HHS) working in the areas of infectious respiratory diseases and national plan and policy development for pandemic influenza preparedness.

Learn More About Julie

Julie Schafer, CTO

Julie Schafer, PhD, MPH, is the Chief Technology Officer for Flu Lab, seeking to stretch the boundaries of how technology is used toward defeating influenza. Julie has held a number of leadership positions in the US Government, including Chief of Staff, and later Director of Strategy, for the Biomedical Advanced Research and Development Authority at the U.S. Department of Health and Human Services (HHS). Julie served in the White House National Security Council and has led complex influenza vaccine, therapeutic, and diagnostic advanced development programs.

Flu Lab's Partners

Collaboration is key to achieving the ambitious goal of defeating influenza which is why Flu Lab works collaboratively with leaders in the influenza ecosystem. We and our partners share an ambition for what can be achieved, a willingness to ask tough questions to get to the root of our challenges, and a desire to approach those challenges in fresh, creative ways and from new angles. Funded organizations are pursuing transformative products, new incentives, and breaking down barriers to success. Together we seek accelerated progress and results.